Skip to main content
Top
Published in: BMC Neurology 1/2022

Open Access 01-12-2022 | Stroke | Research

Influences of different referral modes on clinical outcomes after endovascular therapy for acute ischemic stroke

Authors: Jie Hou, Zhi-liang Guo, Zhi-chao Huang, Huai-shun Wang, Shou-jiang You, Guo-dong Xiao

Published in: BMC Neurology | Issue 1/2022

Login to get access

Abstract

Background and purpose

As endovascular thrombectomy (EVT) is time-dependent, it is crucial to refer patients promptly. Current referral modes include Mothership (MS), Drip and Ship (DS) and Drive the Doctor (DD). The purpose of this study was to investigate the influences of different referral modes on the clinical outcomes of patients with acute ischemic stroke after EVT. 

Methods

A total of 349 patients from 15 hospitals between April 2017 and March 2020 were enrolled. The primary outcomes include poor outcome (modified Rankin Scale score of 3 to 6), symptomatic intracranial hemorrhage transformation (sICH), mortality and cost. Regression analysis was used to assess the association of referral modes with poor outcome, sICH, mortality and cost in acute ischemic stroke patients.

Results

Among the 349 patients, 83 were in DD group (23.78%), 85 in MS group (24.36%) and 181 in DS group (51.86%). There were statistically significant differences in intravenous thrombolysis, onset-to-door time, onset-to-puncture time, puncture-to-recanalization time, door-to-puncture time, door-to-recanalization time, and cost among the DD, MS, and DS groups (59.04% vs 35.29% vs 33.15%, P<0.001; 90 vs 166 vs 170 minutes, P<0.001; 230 vs 270 vs 270 minutes, P<0.001; 82 vs 54 vs 51 minutes, P<0.001; 110 vs 85 vs 96 minutes, P=0.004; 210 vs 146 vs 150 minutes, P<0.001; 64258 vs 80041 vs 70750 Chinese Yuan, P=0.018). In terms of sICH, mortality and poor outcome, there was no significant difference among the DD, MS, and DS groups (22.89% vs 18.82% vs 19.34%, P=0.758; 24.10% vs 24.71% vs 29.83%, P=0.521; 64.47% vs 64.71% vs 68.51%, P=0.827). The results of multiple regression analysis indicated that there was no independent correlation between different referral modes regarding sICH (ORMS: 0.50, 95%CI: 0.18, 1.38, P=0.1830; ORDS: 0.47, 95%CI: 0.19, 1.16, P=0.1000), mortality (ORMS: 0.56, 95%CI: 0.19, 1.67, P=0.2993; ORDS: 0.65, 95%CI: 0.25, 1.69, P=0.3744) and poor outcome (ORMS: 0.61, 95%CI: 0.25, 1.47, P=0.2705; ORDS: 0.53, 95%CI: 0.24, 1.18, P=0.1223). However, there was a correlation between MS group and cost (β=30449.73, 95%CI: 11022.18, 49877.29; P=0.0023). The multiple regression analysis on patients finally admitted in comprehensive stroke center (MS+DS) versus patients finally admitted in primary stroke center (DD) showed that DD mode was independently associated with lower costs (β=-19438.86, 95%CI: -35977.79, -2899.94; P=0.0219).

Conclusion

There was no independent correlation between three referral modes and sICH, mortality, poor outcome correspondingly. Different referral modes can be implemented in clinical practice according to the situations encountered. Compared to MS and DS modes, DD mode is more economical.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fassbender K, Balucani C, Walter S, Levine SR, Haass A, Grotta J. Streamlining of prehospital stroke management: the golden hour. The Lancet Neurology. 2013;12:585–96.CrossRef Fassbender K, Balucani C, Walter S, Levine SR, Haass A, Grotta J. Streamlining of prehospital stroke management: the golden hour. The Lancet Neurology. 2013;12:585–96.CrossRef
2.
go back to reference Serrone JC, Jimenez L, Ringer AJ. The role of endovascular therapy in the treatment of acute ischemic stroke. Neurosurgery. 2014;74(Suppl 1):S133-141.CrossRef Serrone JC, Jimenez L, Ringer AJ. The role of endovascular therapy in the treatment of acute ischemic stroke. Neurosurgery. 2014;74(Suppl 1):S133-141.CrossRef
3.
go back to reference Fassbender K, Grotta JC, Walter S, Grunwald IQ, Ragoschke-Schumm A, Saver JL. Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. The Lancet Neurol. 2017;16:227–37.CrossRef Fassbender K, Grotta JC, Walter S, Grunwald IQ, Ragoschke-Schumm A, Saver JL. Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. The Lancet Neurol. 2017;16:227–37.CrossRef
4.
go back to reference Goyal M, Demchuk AM, Menon BK, et al. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke. N Engl J Med. 2015;372:1019–30.CrossRef Goyal M, Demchuk AM, Menon BK, et al. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke. N Engl J Med. 2015;372:1019–30.CrossRef
5.
go back to reference Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.CrossRef Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.CrossRef
6.
go back to reference Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18.CrossRef Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18.CrossRef
7.
go back to reference Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–95.CrossRef Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–95.CrossRef
8.
go back to reference Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–306.CrossRef Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–306.CrossRef
9.
go back to reference Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. The Lancet. 2016;387:1723–31.CrossRef Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. The Lancet. 2016;387:1723–31.CrossRef
10.
go back to reference Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378:11–21.CrossRef Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378:11–21.CrossRef
11.
go back to reference Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378:708–18.CrossRef Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378:708–18.CrossRef
12.
go back to reference Stahl J, Furie K, Gleason S, Gazelle GJR. Stroke: Effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations. Radiology. 2003;228:659–68.CrossRef Stahl J, Furie K, Gleason S, Gazelle GJR. Stroke: Effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations. Radiology. 2003;228:659–68.CrossRef
13.
go back to reference Kodankandath TV, Wright P, Power PM, et al. Improving Transfer Times for Acute Ischemic Stroke Patients to a Comprehensive Stroke Center. J Stroke Cerebrovasc Dis. 2017;26:192–5.CrossRef Kodankandath TV, Wright P, Power PM, et al. Improving Transfer Times for Acute Ischemic Stroke Patients to a Comprehensive Stroke Center. J Stroke Cerebrovasc Dis. 2017;26:192–5.CrossRef
14.
go back to reference Prabhakaran S, Ward E, John S, et al. Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke. 2011;42:1626–30.CrossRef Prabhakaran S, Ward E, John S, et al. Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke. 2011;42:1626–30.CrossRef
15.
go back to reference Seker F, Fiehler J, Mohlenbruch MA, et al. Time Metrics to Endovascular Thrombectomy in 3 Triage Concepts: A Prospective, Observational Study (NEUROSQUAD). Stroke. 2020;51:335–7.CrossRef Seker F, Fiehler J, Mohlenbruch MA, et al. Time Metrics to Endovascular Thrombectomy in 3 Triage Concepts: A Prospective, Observational Study (NEUROSQUAD). Stroke. 2020;51:335–7.CrossRef
16.
go back to reference Gerschenfeld G, Muresan IP, Blanc R, et al. Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke. JAMA Neurol. 2017;74:549–56.CrossRef Gerschenfeld G, Muresan IP, Blanc R, et al. Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke. JAMA Neurol. 2017;74:549–56.CrossRef
17.
go back to reference Wei D, Oxley TJ, Nistal DA, et al. Mobile Interventional Stroke Teams Lead to Faster Treatment Times for Thrombectomy in Large Vessel Occlusion. Stroke. 2017;48:3295–300.CrossRef Wei D, Oxley TJ, Nistal DA, et al. Mobile Interventional Stroke Teams Lead to Faster Treatment Times for Thrombectomy in Large Vessel Occlusion. Stroke. 2017;48:3295–300.CrossRef
18.
go back to reference Osanai T, Ito Y, Ushikoshi S, et al. Efficacy of “drive and retrieve” as a cooperative method for prompt endovascular treatment for acute ischemic stroke. J Neurointerv Surg. 2019;11:757–61. Osanai T, Ito Y, Ushikoshi S, et al. Efficacy of “drive and retrieve” as a cooperative method for prompt endovascular treatment for acute ischemic stroke. J Neurointerv Surg. 2019;11:757–61.
19.
go back to reference Seker F, Mohlenbruch MA, Nagel S, et al. Clinical results of a new concept of neurothrombectomy coverage at a remote hospital-"drive the doctor". Int J Stroke. 2018;13:696–9.CrossRef Seker F, Mohlenbruch MA, Nagel S, et al. Clinical results of a new concept of neurothrombectomy coverage at a remote hospital-"drive the doctor". Int J Stroke. 2018;13:696–9.CrossRef
20.
go back to reference Kwah LK, Diong J. National Institutes of Health Stroke Scale (NIHSS). J Physiother. 2014;60:61.CrossRef Kwah LK, Diong J. National Institutes of Health Stroke Scale (NIHSS). J Physiother. 2014;60:61.CrossRef
21.
go back to reference Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. The Lancet. 2000;355:1670–4.CrossRef Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. The Lancet. 2000;355:1670–4.CrossRef
22.
go back to reference Zaidat OO, Yoo AJ, Khatri P, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44:2650–63.CrossRef Zaidat OO, Yoo AJ, Khatri P, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44:2650–63.CrossRef
23.
go back to reference Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. The Lancet. 2012;380:1241–9.CrossRef Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. The Lancet. 2012;380:1241–9.CrossRef
24.
go back to reference Hwang YH, Kang DH, Kim YW, Kim YS, Park SP, Liebeskind DS. Impact of time-to-reperfusion on outcome in patients with poor collaterals. AJNR Am J Neuroradiol. 2015;36:495–500. Hwang YH, Kang DH, Kim YW, Kim YS, Park SP, Liebeskind DS. Impact of time-to-reperfusion on outcome in patients with poor collaterals. AJNR Am J Neuroradiol. 2015;36:495–500.
25.
go back to reference Switonska M, Slomka A, Piekus-Slomka N, et al. Does ASTRAL score at hospital admission predict symptomatic haemorrhagic transformation in acute ischaemic stroke after revascularisation? A pilot single-centre study. Neurol Neurochir Pol. 2022;56(2):171–7.CrossRef Switonska M, Slomka A, Piekus-Slomka N, et al. Does ASTRAL score at hospital admission predict symptomatic haemorrhagic transformation in acute ischaemic stroke after revascularisation? A pilot single-centre study. Neurol Neurochir Pol. 2022;56(2):171–7.CrossRef
26.
go back to reference Liu Y, Zhao P, Cheng M, et al. AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study. Lipids Health Dis. 2018;17:275.CrossRef Liu Y, Zhao P, Cheng M, et al. AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study. Lipids Health Dis. 2018;17:275.CrossRef
27.
go back to reference Krishnamoorthy S, Singh G, Jose KJ, et al. Biomarkers in the Prediction of Hemorrhagic Transformation in Acute Stroke: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2022;51:235–47.CrossRef Krishnamoorthy S, Singh G, Jose KJ, et al. Biomarkers in the Prediction of Hemorrhagic Transformation in Acute Stroke: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2022;51:235–47.CrossRef
28.
go back to reference Kijpaisalratana N, Chutinet A, Akarathanawat W, Vongvasinkul P, Suwanwela NC. Outcomes of thrombolytic therapy in acute ischemic stroke: mothership, drip-and-ship, and ship-and-drip paradigms. BMC Neurol. 2020;20:45.CrossRef Kijpaisalratana N, Chutinet A, Akarathanawat W, Vongvasinkul P, Suwanwela NC. Outcomes of thrombolytic therapy in acute ischemic stroke: mothership, drip-and-ship, and ship-and-drip paradigms. BMC Neurol. 2020;20:45.CrossRef
29.
go back to reference Silverman A, Kodali S, Sheth KN, Petersen NH. Hemodynamics and Hemorrhagic Transformation After Endovascular Therapy for Ischemic Stroke. Front Neurol. 2020;11:728.CrossRef Silverman A, Kodali S, Sheth KN, Petersen NH. Hemodynamics and Hemorrhagic Transformation After Endovascular Therapy for Ischemic Stroke. Front Neurol. 2020;11:728.CrossRef
30.
go back to reference Forster A, Gass A, Kern R, et al. Gender differences in acute ischemic stroke: etiology, stroke patterns and response to thrombolysis. Stroke. 2009;40:2428–32.CrossRef Forster A, Gass A, Kern R, et al. Gender differences in acute ischemic stroke: etiology, stroke patterns and response to thrombolysis. Stroke. 2009;40:2428–32.CrossRef
31.
go back to reference Giralt D, Domingues-Montanari S, Mendioroz M, et al. The gender gap in stroke: a meta-analysis. Acta Neurol Scand. 2012;125:83–90.CrossRef Giralt D, Domingues-Montanari S, Mendioroz M, et al. The gender gap in stroke: a meta-analysis. Acta Neurol Scand. 2012;125:83–90.CrossRef
32.
go back to reference Jia B, Feng L, Liebeskind DS, et al. Mechanical thrombectomy and rescue therapy for intracranial large artery occlusion with underlying atherosclerosis. J Neurointerv Surg. 2018;10:746–50.CrossRef Jia B, Feng L, Liebeskind DS, et al. Mechanical thrombectomy and rescue therapy for intracranial large artery occlusion with underlying atherosclerosis. J Neurointerv Surg. 2018;10:746–50.CrossRef
33.
go back to reference Tsang ACO, Orru E, Klostranec JM, et al. Thrombectomy Outcomes of Intracranial Atherosclerosis-Related Occlusions. Stroke. 2019;50:1460–6.CrossRef Tsang ACO, Orru E, Klostranec JM, et al. Thrombectomy Outcomes of Intracranial Atherosclerosis-Related Occlusions. Stroke. 2019;50:1460–6.CrossRef
34.
go back to reference Roy-O’Reilly M, McCullough LD. Age and Sex Are Critical Factors in Ischemic Stroke Pathology. Endocrinology. 2018;159:3120–31. Roy-O’Reilly M, McCullough LD. Age and Sex Are Critical Factors in Ischemic Stroke Pathology. Endocrinology. 2018;159:3120–31.
35.
go back to reference Kunz WG, Hunink MG, Dimitriadis K, et al. Cost-effectiveness of Endovascular Therapy for Acute Ischemic Stroke: A Systematic Review of the Impact of Patient Age. Radiology. 2018;288:518–26.CrossRef Kunz WG, Hunink MG, Dimitriadis K, et al. Cost-effectiveness of Endovascular Therapy for Acute Ischemic Stroke: A Systematic Review of the Impact of Patient Age. Radiology. 2018;288:518–26.CrossRef
36.
go back to reference Simpson KN, Simpson AN, Mauldin PD, et al. Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke. 2014;45:1791–8.CrossRef Simpson KN, Simpson AN, Mauldin PD, et al. Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke. 2014;45:1791–8.CrossRef
37.
go back to reference Barbosa E, Gulela B, Taimo MA, Lopes DM, Offorjebe OA, Risko N. A systematic review of the cost-effectiveness of emergency interventions for stroke in low- and middle-income countries. Afr J Emerg Med. 2020;10:S90–4.CrossRef Barbosa E, Gulela B, Taimo MA, Lopes DM, Offorjebe OA, Risko N. A systematic review of the cost-effectiveness of emergency interventions for stroke in low- and middle-income countries. Afr J Emerg Med. 2020;10:S90–4.CrossRef
38.
go back to reference Saver JL, Goyal M, van der Lugt A, et al. Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. JAMA. 2016;316:1279–88.CrossRef Saver JL, Goyal M, van der Lugt A, et al. Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. JAMA. 2016;316:1279–88.CrossRef
39.
go back to reference Jahan R, Saver JL, Schwamm LH, et al. Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice. JAMA. 2019;322:252–63.CrossRef Jahan R, Saver JL, Schwamm LH, et al. Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice. JAMA. 2019;322:252–63.CrossRef
40.
go back to reference Gonzales S, Mullen M, Skolarus L, Thibault D, Udoeyo U, Willis AJN. Progressive rural-urban disparity in acute stroke care. Neurology. 2017;88:441–8.CrossRef Gonzales S, Mullen M, Skolarus L, Thibault D, Udoeyo U, Willis AJN. Progressive rural-urban disparity in acute stroke care. Neurology. 2017;88:441–8.CrossRef
41.
go back to reference Shi Z-S, Loh Y, Walker G, Duckwiler GR. Clinical Outcomes in Middle Cerebral Artery Trunk Occlusions Versus Secondary Division Occlusions After Mechanical Thrombectomy. Stroke. 2010;41:953–60.CrossRef Shi Z-S, Loh Y, Walker G, Duckwiler GR. Clinical Outcomes in Middle Cerebral Artery Trunk Occlusions Versus Secondary Division Occlusions After Mechanical Thrombectomy. Stroke. 2010;41:953–60.CrossRef
Metadata
Title
Influences of different referral modes on clinical outcomes after endovascular therapy for acute ischemic stroke
Authors
Jie Hou
Zhi-liang Guo
Zhi-chao Huang
Huai-shun Wang
Shou-jiang You
Guo-dong Xiao
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Stroke
Published in
BMC Neurology / Issue 1/2022
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-022-02751-w

Other articles of this Issue 1/2022

BMC Neurology 1/2022 Go to the issue